We are live on
!
Find out more
Level Four Advisory Services Portfolio holdings
AUM
$3.54B
Turnover
13.95%
1-Year Est. Return
37.12%
This Fund
S&P 500
This Quarter
Est. Return
-11.96%
1 Year Est. Return
+37.12%
3 Year Est. Return
+92.23%
5 Year Est. Return
+115.57%
10 Year Est. Return
–
AUM
$1.06B
AUM Growth
-$216M
(-17%)
Cap. Flow
-$52.9M
Cap. Flow
% of AUM
-4.99%
Top 10 Holdings %
Top 10 Hldgs %
20.96%
Holding
680
New
35
Increased
236
Reduced
246
Closed
125
Avg Time Held Equity + Options
2.8
years
Top 10 Avg Time Held Equity + Options
1.4
years
Top 20 Avg Time Held Equity + Options
1.6
years
Avg Time Held Equity only
2.8
years
Top 10 Avg Time Held Equity only
1.4
years
Top 20 Avg Time Held Equity only
1.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Portfolio Intermediate Term Treasury ETF
SPTI
|
+$9.28M |
| 2 |
WisdomTree Floating Rate Treasury Fund
USFR
|
+$7.34M |
| 3 |
Warner Bros
WBD
|
+$4.13M |
| 4 |
NVIDIA
NVDA
|
+$3.07M |
| 5 |
Fidelity Total Bond ETF
FBND
|
+$2.73M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$43.4M |
| 2 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$13.4M |
| 3 |
First Trust Preferred Securities and Income ETF
FPE
|
+$7.85M |
| 4 |
DISCK
Discovery, Inc. Series C Common Stock
DISCK
|
+$3.34M |
| 5 |
Goldman Sachs Hedge Industry VIP ETF
GVIP
|
+$2.98M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 38.64% |
| 2 | Technology | 14.9% |
| 3 | Healthcare | 9.1% |
| 4 | Consumer Staples | 8.71% |
| 5 | Financials | 7.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
251
Nutrien
NTR
$33.2B
| $821K | 0.08% |
10,302
-2,930
| -22% | -$284K |
2019 Q3
11 quarters
|
|
252
State Street Industrial Select Sector SPDR ETF
XLI
$30.6B
| $818K | 0.08% |
9,366
-61
| -0.6% | -$5.75K |
2021 Q4
2 quarters
|
|
253
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$29.4B
| $816K | 0.08% |
7,421
-526
| -7% | -$59.4K |
2016 Q4
22 quarters
|
|
254
Pacira BioSciences
PCRX
$1.45B
| $805K | 0.08% |
13,812
+318
| +2% | +$20.8K |
2022 Q1
1 quarter
|
|
255
Vanguard Health Care ETF
VHT
$19.9B
| $801K | 0.08% |
3,400
-212
| -6% | -$51.1K |
2016 Q4
22 quarters
|
|
256
Vanguard Short-Term Bond ETF
BSV
$45.5B
| $800K | 0.08% |
10,415
-26,702
| -72% | -$2.06M |
2017 Q3
19 quarters
|
|
257
Honeywell
HON
$66.7B
| $799K | 0.08% |
4,876
-944
| -16% | -$170K |
2016 Q4
22 quarters
|
|
258
Kinsale Capital Group
KNSL
$8.15B
| $795K | 0.08% |
+3,462
| New | +$766K |
2022 Q2
0 quarters
|
|
259
St. Joe Company
JOE
$3.86B
| $794K | 0.07% |
20,080
-9,200
| -31% | -$459K |
2021 Q4
2 quarters
|
|
260
GSK
GSK
$98.3B
| $789K | 0.07% |
14,496
+395
| +3% | +$21.8K |
2016 Q4
22 quarters
|
|
261
First Trust Senior Loan Fund ETF
FTSL
$2.49B
| $787K | 0.07% |
17,856
-304
| -2% | -$14K |
2019 Q1
13 quarters
|
|
262
SiTime
SITM
$15.1B
| $781K | 0.07% |
4,793
+1,375
| +40% | +$260K |
2021 Q2
4 quarters
|
|
263
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $777K | 0.07% |
4,066
-360
| -8% | -$63.5K |
2021 Q2
4 quarters
|
|
264
First Trust Technology AlphaDEX Fund
FXL
$2.82B
| $775K | 0.07% |
8,239
-2,863
| -26% | -$295K |
2016 Q4
22 quarters
|
|
265
Cytokinetics
CYTK
$8.89B
| $774K | 0.07% |
19,702
+6,947
| +54% | +$280K |
2022 Q1
1 quarter
|
|
266
DELISTED
Chart Industries
GTLS
| $765K | 0.07% |
4,569
-1,180
| -21% | -$202K |
2021 Q1
5 quarters
|
|
267
PPL Corp
PPL
$26B
| $757K | 0.07% |
27,921
-541
| -2% | -$15.5K |
2021 Q4
2 quarters
|
|
268
Vanguard Short-Term Corporate Bond ETF
VCSH
$44B
| $754K | 0.07% |
9,882
+704
| +8% | +$54.1K |
2021 Q4
2 quarters
|
|
269
Vanguard Information Technology ETF
VGT
$150B
| $754K | 0.07% |
18,464
-896
| -5% | -$40.4K |
2021 Q4
2 quarters
|
|
270
Littelfuse
LFUS
$9.94B
| $748K | 0.07% |
2,943
-436
| -13% | -$109K |
2021 Q1
5 quarters
|
|
271
iShares Morningstar Mid-Cap Value ETF
IMCV
$1.16B
| $747K | 0.07% |
12,582
| – | – |
2016 Q4
22 quarters
|
|
272
Amgen
AMGN
$235B
| $745K | 0.07% |
3,064
-199
| -6% | -$48.8K |
2016 Q4
22 quarters
|
|
273
Supernus Pharmaceuticals
SUPN
$2.3B
| $728K | 0.07% |
25,178
+9,959
| +65% | +$285K |
2021 Q4
2 quarters
|
|
274
Hershey
HSY
$33.9B
| $724K | 0.07% |
3,367
+296
| +10% | +$64.5K |
2018 Q2
16 quarters
|
|
275
Deere & Co
DE
$176B
| $721K | 0.07% |
2,408
-798
| -25% | -$294K |
2016 Q4
22 quarters
|
|
Similar funds
Level Four Advisory Services's Q2 2022 Portfolio in Review
As of Q2 2022, Level Four Advisory Services held 680 positions worth $1.06B, down 17% from $1.28B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Level Four Advisory Services withdrew a net $52.9M in Q2 2022, closing 125 positions and reducing 246 holdings. Its most notable exit was Invesco QQQ Trust, an estimated $43.4M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 39% of assets, down from 41% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Level Four Advisory Services opened a new position in WisdomTree Floating Rate Treasury Fund worth $7.33M.
- Level Four Advisory Services's largest Q2 2022 buy was WisdomTree Floating Rate Treasury Fund: 145,715 shares worth $7.33M.
- Level Four Advisory Services added most to State Street SPDR Portfolio Intermediate Term Treasury ETF in Q2 2022, an estimated $9.28M increase.
- Level Four Advisory Services's biggest Q2 2022 reduction was iShares 7-10 Year Treasury Bond ETF, cutting an estimated $13.4M.
- Level Four Advisory Services fully exited Invesco QQQ Trust in Q2 2022, selling an estimated $43.4M.
- Level Four Advisory Services's ten largest holdings make up 21% of its $1.06B portfolio in Q2 2022.
- Level Four Advisory Services opened 35 new positions and closed 125 in Q2 2022.
- Level Four Advisory Services's portfolio value fell 17% quarter-over-quarter to $1.06B.
Based on Level Four Advisory Services's 13F filing for Q2 2022, filed 8 Aug 2022.